Market capitalization | HKD435.79b |
Enterprise Value | HKD228.24b |
P/E (TTM) P/E ratio | 33.41 |
EV/Sales (TTM) EV/Sales | 10.20 |
P/S ratio (TTM) P/S ratio | 19.48 |
P/B ratio (TTM) P/B ratio | 8.09 |
Dividend yield | 2.69% |
Last dividend (FY24) | HKD9.26 |
Revenue growth (TTM) Revenue growth | 9.06% |
As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.
24 Analysts have issued a Hong Kong Exchanges & Clearing Ltd. forecast:
24 Analysts have issued a Hong Kong Exchanges & Clearing Ltd. forecast:
Dec '24 |
+/-
%
|
||
Revenue | 22,374 22,374 |
9%
9%
|
|
Gross Profit | 19,758 19,758 |
10%
10%
|
|
EBITDA | 16,367 16,367 |
10%
10%
|
EBIT (Operating Income) EBIT | 14,965 14,965 |
11%
11%
|
Net Profit | 13,050 13,050 |
10%
10%
|
In millions HKD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Hong Kong Exchanges & Clearing Ltd. engages in the operation of stock and futures markets. It operates though the following segments: Cash; Equity and Financial Derivatives; Commodities; Clearing; and Platform and Infrastructure. The Cash segment covers equity products traded on the Cash Market platforms and Shanghai Stock Exchange. The Equity and Financial Derivatives segment includes derivatives products traded on Hong Kong Futures Exchange Limited and the Stock Exchange, and other related activities. The Commodities segment operates an exchange in the United Kingdom for the trading of base metals futures and options contracts. The Clearing segment provides clearing, settlement, depository, and custody and nominee services. The Platform and Infrastructure segment refers to services in connection with providing users with access to the platform and infrastructure. The company was founded on July 8, 1999 and is headquartered in Hong Kong.
Head office | Hong Kong |
CEO | Yiting Chan |
Founded | 1999 |
Website | www.hkex.com.hk |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.